SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

Reduction in HPV Prevalence— No Evidence to Support HPV Vaccination reduces HPV Prevalence

By

Authors:  Jennifer A. Groner1, George D. Harris2 and Diane M. Harper3,4,5  TO THE EDITOR—The recent Centers for Disease Control and Prevention (CDC) study by Markowitz et al [1] provides limited and inconclusive data on 111 sexually active females between 14 and 19 years of age who received at least 1 dose of quadrivalent human papillomavirus vaccine (HPV4). The […]

[Continue reading...]

Human papillomavirus (HPV) is not the main cause of preinvasive and invasive cervical cancer among patients in Delta Region, Egypt

By

Is 'protecting' against 4 types of HPV enough to warrant the risks?

Human papillomavirus (HPV) is not the main cause of preinvasive and invasive cervical cancer among patients in Delta Region, Egypt Authors: Thabet M, Hemida R, Hasan M, Elshamy M, Elfaraash M, Emam M. Abstract BACKGROUND: Cervical cancer remains a significant problem worldwide particularly in underdeveloped countries. It is necessary to have a persistent infection of the […]

[Continue reading...]

Human Papillomavirus in Infants: Transmission, HPV Prevalence, and Persistence

By

Is 'protecting' against 4 types of HPV enough to warrant the risks?

HPV Prevalence, and Persistence Author: Delese E. LaCour, MD* Introduction HPV prevalence. Infections caused by human papillomavirus (HPV) result in considerable morbidity and mortality throughout the world.1–4 Conditions such as anogenital warts, caused by low-risk HPV genotypes and cervical dysplasia, more commonly caused by oncogenic HPV types, can affect females in all age groups.5–9 The prevalence […]

[Continue reading...]

Reduction in HPV prevalence?

By Leave a Comment

Is 'protecting' against 4 types of HPV enough to warrant the risks?

[SaneVax: Following is an excerpt from a letter to the editor of The Journal of Infectious Diseases that provides a critique of a scientific study used to demonstrate the success of HPV vaccination programs in the United States. Evidently, things are not so cut and dried as the CDC would like us to believe.] Reduction in HPV Prevalence—No […]

[Continue reading...]

HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia

By Leave a Comment

Genetic Predisposition Corresponding author: Ghazi Alsbeih galsbeih@kfshrc.edu.sa Background Cervical cancer incidence is low in Saudi Arabian women, suggesting low prevalence to HPV infection due to environmental, cultural and genetic differences. Therefore, we investigated HPV prevalence and genotype distribution in cervical cancer as well as the association with 9 genetic single nucleotide polymorphisms (SNPs): CDKN1A (p21) C31A, TP53 C72G, ATM G1853A, HDM2promoter T309G, HDM2 A110G, LIG4 A591G, XRCC1 G399A, XRCC3 C241T and TGFβ1 T10C, […]

[Continue reading...]

SANE Vax to CDC: Request for additional data on HPV vaccine post-marketing monitoring

By 1 Comment

Lauri Markowitz, M.D. Centers for Disease Control and Prevention MS E05, 1600 Clifton Road Atlanta, GA 30333 lem2@cdc.govAugust 31, 2011 Dear Dr. Markowitz: Thank you for your August 29, 2011 response to my letter requesting additional information about post licensure monitoring for Gardasil™ from the CDC. Before relaying your response to medical consumers, I would […]

[Continue reading...]

Human papillomavirus genotype distribution among French women with and without cervical abnormalities

By

Casalegno JS, Benchaib M, Le Bail Carval K, Piaton E, Mathevet P, Mekki Y. Source Laboratory of Virology, Femme-Mère-Enfant Hospital, Bron, France. Abstract OBJECTIVE: To assess human papillomavirus (HPV) prevalence and distribution among French women with normal and pathologic cytology findings. METHODS: A genomic DNA microarray assay enabling the detection of 35 different HPV genotypes […]

[Continue reading...]

Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy

By

Tornesello ML, Duraturo ML, Buonaguro L, Vallefuoco G, Piccoli R, Palmieri S, Buonaguro FM. Source Viral Oncology and AIDS Reference Centre, National Cancer Institute, Fond. Pascale, Naples, Italy. mltornesello@virgilio.it Abstract BACKGROUND: The distribution of human papillomaviruses (HPVs) varies greatly across populations and HPV surveys have been performed in different geographical regions in order to apply […]

[Continue reading...]

Prevalence and Risk Factors of Human Papillomavirus (HPV) Infection in Southern Chinese Women – A Population-Based Study

By

Stephanie Si Liu1, Kelvin Yuen Kwong Chan1, Rebecca Ching Yu Leung1, Karen Kar Loen Chan1, Kar Fai Tam1, May Hiu Mei Luk5, Sue Seen Tsing Lo4, Daniel Yee Tak Fong3, Annie Nga Yin Cheung2, Zhong Qiu Lin5*, Hextan Yuen Sheung Ngan1* ABSTRACT: Background Persistent high-risk type Human papillomavirus (HPV) infection is recognized as a necessary […]

[Continue reading...]

Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women.

By Leave a Comment

Correnti M, Medina F, Cavazza ME, Rennola A, Avila M, Fernándes A. Abstract OBJECTIVE: Cervical cancer is an important cause of mortality among women in developing countries, especially in the Latin America and Caribbean (LAC) region. Infection with high-risk (HR) human papillomavirus (HPV) has been identified as the primary cause of cervical cancer. The aim […]

[Continue reading...]

High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women

By 1 Comment

Angela Watt, David Garwood, Maria Jackson, Novie Younger, Monica Smikle, Horace Fletcher and Norma McFarlane-Anderson Infection with oncogenic human papillomavirus (HPV)types is the primary cause of cervical cancer, the second most common cancer among women worldwide [1]. In developing countries, cervical cancer is second to breast cancer as the cause of cancer deaths in women […]

[Continue reading...]

Oncogenic HPV among HIV infected female population in West Bengal India

By Leave a Comment

Prevalence of both cervical cancer and Human Immunodeficiency Virus (HIV) infection are very high in India. Natural history of Human Papilloma Virus (HPV) infection is known to be altered in HIV positive women and there is an increased possibility of persistence of HPV infections in this population. Therefore, this study was conducted to understand the […]

[Continue reading...]

Norwegian Institute for Public Health: Large National HPV Study Underway

By

A simple urine test can provide important answers Published  03 February 2011 The first 17-year-old girls are now receiving an invitation to participate in a pilot study in advance of a planned nationwide research on the prevalence of human papillomavirus (HPV). Urine samples will be collected and tested for HPV. The purpose is to get […]

[Continue reading...]

News

Videos

Contact